HIT Consultant March 26, 2021
Dr. Robert S. Miller, Medical Director of CancerLinQ

Despite decades of scientific progress against cancer, access to treatment remains highly unequal. Some of the reasons — like institutional racism and poverty — are a reflection of our broader society. Other inequities may go unrecognized but are no less damaging. People with underlying health conditions, for example, may be excluded from clinical trials, preventing them from accessing leading-edge treatments and limiting the evidence available to guide their care.

With multiple drivers of inequity, we need multiple solutions. Every sector of the healthcare system — health systems, research sponsors, clinicians, payers, and policymakers alike – must do their part.

Those of us working at the intersection of clinical care and data science are no exception. My organization, for example, is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Big Data, EMR / EHR, Equity/SDOH, Health IT, Healthcare System, Patient / Consumer, Provider, Technology
The Ripple Effect: Ways to Make Health in All Policies Stick in Kansas and Beyond to Enhance Health and Equity
Katie Couric Talks Colon Cancer, Health Equity And AI
Ernst & Young: Health equity efforts maturing, but data capabilities remain barrier
Research Funding Is Needed To Support An Effective, Equitable, And Sustainable Public Health System
Transforming The Narrative On Homelessness

Share This Article